Cargando…

Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease()

In Parkinson's disease (PD) the demonstration of neuropathological disturbances in nigrostriatal and extranigral brain pathways using magnetic resonance imaging remains a challenge. Here, we applied a novel diffusion-weighted imaging approach—track density imaging (TDI). Twenty-seven non-dement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziegler, Erik, Rouillard, Maud, André, Elodie, Coolen, Tim, Stender, Johan, Balteau, Evelyne, Phillips, Christophe, Garraux, Gaëtan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121087/ https://www.ncbi.nlm.nih.gov/pubmed/24956065 http://dx.doi.org/10.1016/j.neuroimage.2014.06.033

Ejemplares similares

Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
por: Depierreux, Frédérique, et al.
Publicado: (2021)

VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease
por: Taylor, Tonya N., et al.
Publicado: (2011)

Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease
por: Wise, John P., et al.
Publicado: (2018)

Altered White Matter Architecture in BDNF Met Carriers
por: Ziegler, Erik, et al.
Publicado: (2013)

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016)

The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson’s Disease
por: D’Ostilio, Kevin, et al.
Publicado: (2016)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Evidence for a Role of a Cortico-Subcortical Network for Automatic and Unconscious Motor Inhibition of Manual Responses
por: D’Ostilio, Kevin, et al.
Publicado: (2012)

Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease
por: Du, Guangwei, et al.
Publicado: (2012)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Impaired automatic and unconscious motor processes in Parkinson's disease
por: D'Ostilio, Kevin, et al.
Publicado: (2013)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson’s Disease
por: Wilkinson, Hayden, et al.
Publicado: (2021)

The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
por: Blokhin, Victor, et al.
Publicado: (2022)

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes()()
por: Garraux, Gaëtan, et al.
Publicado: (2013)

Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease rats☆
por: Zhou, Qingwei, et al.
Publicado: (2012)

Multivariate Analysis of (18)F-DMFP PET Data to Assist the Diagnosis of Parkinsonism
por: Segovia, Fermín, et al.
Publicado: (2017)

Using quantitative magnetic resonance imaging to track cerebral alterations in multiple sclerosis brain: A longitudinal study
por: Vandeleene, Nora, et al.
Publicado: (2023)

Allopregnanolone and neurogenesis in the nigrostriatal tract
por: Wang, Jun Ming
Publicado: (2014)

Metabolic Covariant Network in Relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-Related Parkinsonism
por: Chang, Chiung-Chih, et al.
Publicado: (2016)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
por: Caminiti, Silvia Paola, et al.
Publicado: (2017)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
por: Wang, Jing, et al.
Publicado: (2020)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson’s disease
por: Tang, Lei, et al.
Publicado: (2023)

Finger Tapping Clinimetric Score Prediction in Parkinson's Disease Using Low-Cost Accelerometers
por: Stamatakis, Julien, et al.
Publicado: (2013)

Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease
por: Vernon, Anthony C, et al.
Publicado: (2010)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2011)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
por: López-Aguirre, M., et al.
Publicado: (2023)

Automatic Stimulus-Induced Medial Premotor Cortex Activation without Perception or Action
por: D'Ostilio, Kevin, et al.
Publicado: (2011)

Brain mechanisms underlying automatic and unconscious control of motor action
por: D'Ostilio, Kevin, et al.
Publicado: (2012)

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
por: Perlbarg, Vincent, et al.
Publicado: (2018)

3433 Tissue Engineered Nigrostriatal Pathway as a Test-Bed for Evaluating Axonal Pathophysiology in Parkinson’s disease
por: Clark, Elisia, et al.
Publicado: (2019)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
por: Cao, Ruihua, et al.
Publicado: (2020)

Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson’s Disease
por: Quarantelli, Mario, et al.
Publicado: (2022)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
por: Machado, A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_647t5b22g6kut3045i7euejsfv